№ files_lp_4_process_2_73521
File format: docx
Character count: 11
File size: 1887 KB
Corporate name entry identifying the banking and financial services institution MCB Bank Ltd.
Name:
MCB Bank Ltd.
Entity Type:
Banking institution
Legal Form:
Limited company
Industry:
Banking and financial services
Document Form:
Organizational name entry
Language:
English
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Course Code:
MCB 424
Term:
Spring 2024
Credits:
3 Credit Hours
Instructor:
William Metcalf
Instructor Email:
[email protected]
Instructor Office:
B415 CLSL
Instructor Office Hours:
Mondays 4:00 – 5:00 PM, or by appointment
Teaching Assistant:
Divyanshi
TA Email:
[email protected]
TA Office:
Learning Center, Burrill Hall
TA Office Hours:
Wednesdays 8:50 – 9:50, or by appointment
Class Schedule:
Monday, Wednesday, Friday 10:00 – 10:50 PM
Classroom:
140 Burrill Hall
Prerequisites:
MCB 250 and MCB 354 or MCB 450, or consent of instructor
Course Text:
The physiology and biochemistry of prokaryotes by David White
Other Texts:
Biology of the Prokaryotes, Bacterial Metabolism
Course Website:
http://www.life.illinois.edu/mcb/424
Grading:
Option I (400 points) or Option II (600 points)
Assessments:
3 Exams, 6 Problem Sets, 1 Quiz, Muddiest Points, Final Exam (optional)
Problem Set Deadlines:
February 2, February 14, March 6, March 26, April 10, April 26
Exams:
February 16, March 27, April 29
Optional Final Exam:
May 10, 1:30–4:30 PM
Policies:
MCB Curriculum Policies, Religious Observances, Late Add, Contacting Course Personnel
Learning Outcomes:
Understanding microbial metabolism, energy conservation, adaptation to environments, predicting metabolic pathways
Target Audience:
Undergraduate students in Molecular & Cellular Biology
Year:
Not specified
Region / City:
Not specified
Theme:
Electrical components, circuit breakers
Document type:
Technical specification
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Electrical engineers, manufacturers, and users of electrical systems
Effective period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Note:
Description
Year:
2019–2020
Region / city:
Australia
Theme:
Disability Services, Health Care
Document Type:
Grant Opportunity Guidelines
Organization / Institution:
National Disability Insurance Agency (NDIA), Community Grants Hub
Author:
National Disability Insurance Agency (NDIA)
Target Audience:
Organizations and individuals applying for disability-related grants
Period of validity:
2019–2020
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2022
Region / City:
Massachusetts, USA
Topic:
Vocational and Social Rehabilitation, Blind and Visually Impaired Services
Document Type:
Meeting Minutes
Organization / Agency:
Massachusetts Commission for the Blind (MCB)
Attendees:
SAB members, MCB staff, public representatives
Author:
Secretary of the SAB
Target Audience:
SAB members, MCB staff, general public
Period Covered:
February 11, 2022
Meeting Recorded:
Yes
Staffing Information:
Detailed FTE allocations and staffing cap issues
Budget and Financials:
FY 2022 staffing cap, FY 2023 budget considerations
Policy Updates:
Proposed regulations on data sharing with city/town assessors
Next Meeting:
March 28, 2022
Year:
2005
Region / City:
Strasbourg
Theme:
Human rights, property law
Document type:
Court ruling
Authority:
European Court of Human Rights
Author:
European Court of Human Rights
Target audience:
Legal professionals, scholars
Period of validity:
N/A
Date of adoption:
15 November 2005
Date of revision:
30 August 2007
Year:
2018
Region / City:
Australian Capital Territory
Topic:
Administrative Review, Land Development
Document Type:
Legal Decision
Authority / Institution:
ACT Civil and Administrative Tribunal
Author:
Senior Member G Lunney SC, Senior Member R Pegrum
Target Audience:
Legal Professionals, Planners, Developers
Period of Action:
2017-2018
Approval Date:
14 December 2017
Date of Decision:
20 April 2018
Legislation Cited:
ACT Civil and Administrative Tribunal Act 2008 s 68, Planning and Development Act 2007 ss 48, 50, 53, 55, 113, 119, 120, 407
Cases Cited:
Morozow v ACT Planning and Land Authority [2017] ACAT 79
Contextual Description:
A legal decision regarding the approval and conditions for the construction of a single-storey building containing a restaurant and takeaway food shop, including associated works and conditions on land use in the Australian Capital Territory.
Year:
2023
Region / City:
Pelindaba, Brits, South Africa
Theme:
Nuclear Energy, Medical Radioisotopes, Procurement
Document Type:
Invitation to Bid
Organization:
South African Nuclear Energy Corporation SOC Ltd (Necsa)
Author:
Not specified
Target Audience:
Bidders, Suppliers
Validity Period:
90 Days
Approval Date:
Not specified
Amendment Date:
24 November 2023
Year:
2025
Region / City:
Machakos
Subject:
Civil appeal, legal procedure
Document Type:
Court ruling
Author:
Chief Magistrate B. Ojoo
Target Audience:
Legal professionals, parties involved in the case
Period of validity:
2025
Date of approval:
2025
Date of changes:
N/A
Year:
2020
Region / city:
Australia
Topic:
Biosimilar medicine submission
Document type:
Pharmaceutical submission
Organization / institution:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Maxx Pharma Pty Ltd
Target audience:
Healthcare professionals, regulatory bodies
Period of validity:
Ongoing
Approval date:
November 2022
Modification date:
November 2022
Year:
2025
Region / City:
Australia
Topic:
Pharmaceutical submission for drug listing
Document Type:
Pharmaceutical submission
Organization:
Janssen-Cilag Pty Ltd
Author:
Not specified
Target Audience:
Healthcare professionals, regulatory authorities
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
March 2025
Note:
Context
Year:
2023
Region / City:
Australia
Theme:
Medicine, Oncology
Document Type:
Submission Report
Organization / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Healthcare professionals, regulators
Period of Validity:
Ongoing
Approval Date:
28 March 2023
Modification Date:
December 2022
Year:
2025
Region / City:
South Africa
Subject:
Insolvency and liquidation claim procedures
Document Type:
Legal Form
Organ / Institution:
Liquidation Office
Author:
Not specified
Target Audience:
Creditors of the Insolvent Estate
Period of Effect:
From date of sequestration/liquidation
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2024
Region / City:
Australia
Topic:
Medicinal Product Registration
Document Type:
Submission Report
Agency:
Therapeutic Goods Administration (TGA)
Author:
GlaxoSmithKline Australia
Target Audience:
Medical Practitioners
Treatment Phase:
Initial Treatment
Indication:
Myelofibrosis, including primary, post-polycythaemia vera, and post-essential thrombocythaemia myelofibrosis
Approval Status:
Pending
Date of Submission:
May 2024
Date of Approval:
Not yet approved
Background:
Momelotinib is currently approved in the UK, US, Japan, and the EU.
Description:
Clinical submission for listing momelotinib under the Australian PBS for the treatment of myelofibrosis in patients with moderate to severe anaemia.
Year:
2023
Region / city:
Australia
Theme:
Pharmaceutical submission
Document type:
Pharmaceutical submission
Organization / institution:
Pfizer Australia Pty Ltd
Author:
Not specified
Target audience:
Medical practitioners, nurse practitioners
Effective period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Context:
Pharmaceutical submission requesting the inclusion of a new formulation of methotrexate under the General Schedule of the PBS for Australia, with changes in packaging and excipient composition.
Year:
2023
Region / city:
Australia
Topic:
Vedolizumab submission for chronic pouchitis treatment
Document type:
Submission for listing of medicinal product
Agency:
Therapeutic Goods Administration (TGA)
Author:
Takeda Pharmaceuticals Australia Pty. Ltd.
Target audience:
Healthcare professionals, regulatory authorities
Effective period:
From 29 June 2023
Approval date:
29 June 2023
Modification date:
N/A
Year:
2023
Region / City:
United Kingdom
Subject:
Maritime Labour Convention Compliance
Document Type:
Application Form
Organization:
United Kingdom Mutual Steam Ship Assurance Association Ltd or UK P&I Club N.V.
Author:
Not specified
Target Audience:
Shipowners, maritime companies
Period of Validity:
From 20 February 2023 to 20 February 2024
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2022
Region / City:
Australia
Topic:
Medical treatment approval and submission for pembrolizumab and lenvatinib
Document type:
Submission for drug listing
Organization / Institution:
Pharmaceutical Benefits Advisory Committee (PBAC), Therapeutic Goods Administration (TGA)
Author:
Merck Sharp & Dohme (Australia) Pty Ltd
Target audience:
Medical professionals, health regulators
Period of validity:
2022 onward
Approval date:
August 10, 2021
Amendment date:
Not specified
Year:
2023
Region / city:
Australia
Theme:
Oncology, Chronic Lymphocytic Leukaemia
Document Type:
Resubmission Report
Organization:
AstraZeneca Pty Ltd
Author:
Not specified
Target Audience:
Medical professionals, healthcare policymakers
Period of validity:
Not specified
Approval Date:
November 2019
Date of Changes:
December 2022
Year:
2022
Region / City:
Johannesburg
Subject:
Legal dispute regarding eviction and payment failure
Document Type:
Judgment
Organ / Institution:
High Court of South Africa
Author:
Bester AJ
Target Audience:
Legal professionals, parties involved in the case
Effective Period:
2022-2023
Approval Date:
2022
Date of Changes:
None
Year:
2014–2015
Organization:
Department of Housing and Public Works
Document type:
Clause Bank / Legal Reference
Subject:
Standard contracts, alternative clauses, intellectual property, confidentiality
Authors:
Sam Mathers (PTD)
Reviewers:
Kerry Harding (DHPW Legal)
Version history:
V1.0, V1.1, V1.2
Effective period:
As per individual contract execution
Intended audience:
Customers and Suppliers under Government contracts